Rapid symptomatic improvement in gefitinib-treated patients with EGFR-mutated lung cancer: possible role of downregulation of inflammatory molecules?

Onkologie. 2011;34(10):559-60. doi: 10.1159/000332123. Epub 2011 Sep 16.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / genetics*
  • Adenocarcinoma / pathology
  • Adenocarcinoma / surgery
  • Adult
  • Antineoplastic Agents / therapeutic use*
  • DNA Mutational Analysis*
  • Down-Regulation / drug effects*
  • Down-Regulation / genetics*
  • ErbB Receptors / antagonists & inhibitors*
  • ErbB Receptors / genetics*
  • Female
  • Gefitinib
  • Humans
  • Inflammation Mediators / metabolism*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery
  • Lymphatic Metastasis
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Quinazolines / therapeutic use*
  • Tomography, X-Ray Computed

Substances

  • Antineoplastic Agents
  • Inflammation Mediators
  • Quinazolines
  • EGFR protein, human
  • ErbB Receptors
  • Gefitinib